Patent Year in Review: Key Decisions, Trends, and Strategies
Doctrine of Equivalents, PTAB Appeals, Obviousness, Written Description, Inequitable Conduct, and More
A live 90-minute premium CLE video webinar with interactive Q&A
This CLE webinar will guide patent counsel on recent trends and developments in patent practice. The panel will examine the Supreme Court, Federal Circuit, and PTAB cases from the past year and discuss some of the key developments and strategies.
Outline
- Supreme Court decision
- Federal Circuit decisions
- Doctrine of equivalents
- Section 103
- Section 112
- Inventorship/ownership
- Claim construction
- Inequitable conduct
- PTAB appeals
- Important PTAB decisions
Benefits
The panel will review these and other key issues:
- Key patent decisions in the Federal Circuit and Supreme Court and the impact on patent practice
- Impact of recent PTAB decisions on patent practice
- Lessons from recent decisions and strategies going forward
Faculty

Michele C. Bosch
Partner
Finnegan Henderson Farabow Garrett & Dunner
Ms. Bosch leads the firm’s Chemical and Metallurgical practice group. Her practice includes many areas of... | Read More
Ms. Bosch leads the firm’s Chemical and Metallurgical practice group. Her practice includes many areas of intellectual property law with an emphasis on post-grant proceedings, including inter partes review (IPR), post-grant review (PGR) and patent interference proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO); portfolio management and analysis; due diligence investigations; pre-litigation analysis; and comprehensive strategic client counseling in the life sciences, consumer product, petrochemical and organic chemical areas.
Close
Paul W. Browning, Ph.D.
Partner
Finnegan Henderson Farabow Garrett & Dunner
Dr. Browning focuses on patent litigation and appeals. He has led teams as first chair at trial, at Markman... | Read More
Dr. Browning focuses on patent litigation and appeals. He has led teams as first chair at trial, at Markman proceedings, and on appeal. His litigation experience includes taking and cross examining witnesses at trial, briefing and arguing dispositive motions, drafting appellate briefs, and arguing cases on appeal. He has also managed day-to-day litigation activities in actions involving multiple parties. In addition, he advises clients on patent matters, including coordination of prosecution and U.S. and foreign litigation strategy.
Close
Thomas L. Irving
Partner
Finnegan Henderson Farabow Garrett & Dunner
Mr. Irving has 35 years of experience in the field of IP law. His practice includes due diligence, patent prosecution,... | Read More
Mr. Irving has 35 years of experience in the field of IP law. His practice includes due diligence, patent prosecution, reissue and reexamination, patent interferences, and counseling, including prelitigation, Orange Book listings of patents covering FDA-approved drugs, and infringement and validity analysis in the chemical fields, as well as litigation. He has served as lead counsel in many patent interferences.
Close
Brooke M. Wilner
Attorney
Finnegan Henderson Farabow Garrett & Dunner
Ms. Wilner’s practice includes patent litigation, patent prosecution, and proceedings before the U.S. Patent and... | Read More
Ms. Wilner’s practice includes patent litigation, patent prosecution, and proceedings before the U.S. Patent and Trademark Office (USPTO). She has technical experience in the aerospace engineering field, including vertical take-off and landing aircraft and unmanned aerial systems. Ms. Wilner has experience in both trial and appellate practice, including district court litigation, post-grant proceedings at the USPTO, and appeals to the U.S. Court of Appeals for the Federal Circuit. She has also assisted with the prosecution of utility patents.
Close
Xiaoguang Michelle Gao, Ph.D., J.D.
Assistant General Patent Counsel
Eli Lilly and Company
Dr. Gao provides IP support for Lilly BioMedicines assets and the Lilly Biotechnology Center in San Diego. She... | Read More
Dr. Gao provides IP support for Lilly BioMedicines assets and the Lilly Biotechnology Center in San Diego. She obtained her Ph.D. in Molecular Biology from Northwestern University, and J.D. from the University of Illinois. Prior to joining Eli Lilly, she was a Patent Attorney at Novartis Institutes for BioMedical Research, where she supported ImmunoOncology and Neuroscience programs. She also worked for Fish & Richardson as an associate, focusing her practice on biopharma-related patent prosecution and litigation there.
CloseLive Webinar
Buy Live Webinar
Early Discount (through 01/29/21)
Live Webinar
$297